arginine has been researched along with Pneumonia, Bacterial in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, F; Chen, H; Chen, L; Cheng, Z; Dong, Y; Fan, Z; Jin, S; Jin, Y; Lin, J; Liu, C; Pan, X; Shi, J; Tian, Z; Wei, Y; Wu, W | 1 |
| Douda, D; Ghorbani, P; Grasemann, H; Huang, H; Mehl, A; Palaniyar, N; Ratjen, F | 1 |
| Cockcroft, DW; Gordon, JR; Li, F; Town, JR; Zhang, X; Zhao, X | 1 |
| Aranda, JV; Glibetic, M; Natarajan, G; Ofenstein, JP; Raykova, V; Thomas, RL | 1 |
4 other study(ies) available for arginine and Pneumonia, Bacterial
| Article | Year |
|---|---|
PvrA is a novel regulator that contributes to Pseudomonas aeruginosa pathogenesis by controlling bacterial utilization of long chain fatty acids.
Topics: Animals; Arginine; Bacterial Proteins; Base Sequence; Chromatin Immunoprecipitation; Disease Models, Animal; Fatty Acids; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genes, Bacterial; Ligands; Mice; Models, Molecular; Mutation; Palmitic Acid; Palmitoyl Coenzyme A; Phosphatidylcholines; Pneumonia, Bacterial; Promoter Regions, Genetic; Pseudomonas aeruginosa; Transcriptome; Virulence | 2020 |
Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumonia.
Topics: Animals; Arginase; Arginine; Female; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pneumonia, Bacterial; Pseudomonas aeruginosa | 2014 |
ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
Topics: Amino Acid Motifs; Animals; Arginine; Cattle; Cell Line; Chemotaxis, Leukocyte; Endotoxemia; Glutamic Acid; Guinea Pigs; Humans; Inflammation; Inflammation Mediators; Interleukin-8; Leucine; Ligands; Neutrophil Activation; Neutrophils; Pneumonia, Bacterial; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Respiratory Mucosa | 2009 |
Nitric oxide and prostaglandin response to group B streptococcal infection in the lung.
Topics: Animals; Arginine; Cell Line; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Gene Expression Regulation; Guanidines; Humans; Male; Nitric Oxide; Nitric Oxide Synthase; Pneumonia, Bacterial; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptococcal Infections; Streptococcus agalactiae | 2007 |